January 26, 2023 Comments Off on New patent expiration for Merck Sharp drug JUVISYNC Posted in: Uncategorized
Annual Drug Patent Expirations for JUVISYNC Juvisync is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are four patents protecting this drug and three…
The post New patent expiration for Merck Sharp drug JUVISYNC appeared first …
January 26, 2023 Comments Off on New patent expiration for Merck Sharp drug JANUMET XR Posted in: Uncategorized
Annual Drug Patent Expirations for JANUMET+XR Janumet Xr is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Merck Sharp drug JANUMET XR appeared first on …
